Neurologist Robert Fox, MD, is the 2018 Sones Innovation Award honoree for leading pioneering advancements in brain imaging and treatment of the challenging progressive form of multiple sclerosis.
Information-Guided Neurological Care Is at Hand
An information-guided approach to care — involving brain mapping, image post-processing and more — is leading to enhanced diagnosis and more-personalized treatments in patients with complex neurological diseases.
Disability Progression Slowed for First Time in Large Trial of Secondary Progressive MS
Results of the phase 3 EXPAND trial suggest that siponimod may help fill the void of useful therapies for patients with secondary progressive multiple sclerosis.
An Important but Limited Step Forward in Personalized Multiple Sclerosis Care
The first evidence has emerged that short-term response to MS treatment is related to the underlying inflammatory pathology in MS lesions. An expert puts the findings in context.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
SPRINT-MS: Ibudilast Shows Unprecedented Slowing of Brain Atrophy in Progressive MS
The novel therapy cut the rate of brain volume loss by nearly half relative to placebo in the notoriously treatment-refractory progressive form of multiple sclerosis. What’s ahead for ibudilast?